Press release
The on-body drug delivery-related intellectual landscape report identifies and analyzes all relevant IP publications, featuring the contributions of both established and emerging technology developers
Roots Analysis has announced the addition of the “On-body Drug Delivery Devices - Intellectual Property Landscape: Focus on Popular / Relevant Prior Art Search Expressions, Patent Valuation, Pockets of Innovation / White Spaces, and Key Applicant Profiles” report to its list of offerings.
Since the early 20th century, over 12,000 patents / patent applications have been granted / filed in relation to drug delivery devices that can either be worn on the body (or implanted), by both industry and non-industry players. Presently, innovation in this domain is focused on developing cheaper and more environment friendly drug delivery systems, with provisions to minimize / altogether eliminate the risk of needlestick injuries.
To order this report, featuring [A] a comprehensive MS Excel datasheet and [B] a detailed summary in MS PowerPoint, please visit this link - https://www.rootsanalysis.com/reports/on-body-drug-delivery-devices-intellectual-property-landscape.html
Key Product Highlights
From 2001 onwards, over 9,600 applications, featuring different types of IP documents, have been filed and published across different jurisdictions, worldwide
Although several patents related to on-body injectors have already been granted, the major corpus of published IP literature is patent applications; other prominent documents include search reports, amended patents and limited patents.
Based on frequency of use, we identified close to 20 domain specific terms that can be used for impactful prior art searches
An analysis of the titles of IP documents related to this particular field revealed infusion pumps, patch pumps and implants to be the preferred choice of keywords describing this particular type of innovation. Most of the IP publications captured in the report describe technologies designed to facilitate the infusion (as observed in 2,300+ titles) of pharmacological fluids.
Close to 650 IP publications emerged as the most valuable documents related to innovations described in contemporary patent literature
Taking into consideration multiple relevant parameters, the report includes a competitive benchmarking and valuation analysis, which offers important insights into the various factors influencing the relative value associated with granted patents, patent applications and other IP publications related to on-body (and implantable) drug delivery devices.
The report focuses on 40 key pockets of innovation (in terms of CPC families and symbols); there are also several companies making attempts to identify and address key white spaces
Considering the primary purpose of portable drug delivery solutions, most of the innovation in this field of research is focused on tools / technologies to safely facilitate the transfer of large volumes of fluids into the body. Despite the proven versatility of on-body / implantable therapy injectors, there are multiple unaddressed areas of concern (mostly related to improving drug delivery features) that are gradually being taken up by stakeholders.
To request a sample copy / brochure of this report, please visit this link - https://www.rootsanalysis.com/reports/on-body-drug-delivery-devices-intellectual-property-landscape.html
Key Questions Answered
What are the various types of IP documents that have been published in relation to on-body drug delivery devices?
What are the key search expressions that can be used to effectively lookup technical documents, describing innovations in wearable / implantable drug delivery solutions?
What is the relative valuation of a particular IP document, or set of IP documents, in comparison to others in the IP landscape?
Who are the current owners of the high value patents related to on-body drug delivery technologies?
What are the key areas of innovation and in what direction is the research in this field, likely to evolve in future?
Who are the most prolific patent applicants in the on-body drug delivery devices IP landscape?
The research includes profiles of key IP applicants (listed below) engaged in this domain; each profile features an overview of the company, financial information (if available), and its proprietary IP related trends.
Amgen
Becton Dickinson
Bigfoot Biomedical
Codman & Shurtleff
DCA Design International
Deka Products
Insulet Corporation
Medtronic
Novo Nordisk
Roche (including the contributions of Roche Diagnostics and Roche Diabetes Care)
Sanofi Aventis
Smiths Medical
Tandem Diabetes Care
For additional details, please visit
https://www.rootsanalysis.com/reports/on-body-drug-delivery-devices-intellectual-property-landscape.html or email sales@rootsanalysis.com
You may also be interested in the following titles:
1. Large Volume Wearable Injectors Market (5th Edition), 2020-2030
2. Novel Drug Reconstitution Systems Market: Industry Trends and Global Forecasts, 2021-2030
3. Novel Ocular Drug Delivery Devices Market: Industry Trends and Global Forecast, 2021-2030
Contact:
Gaurav Chaudhary
+1 (415) 800 3415
+44 (122) 391 1091
Gaurav.Chaudhary@rootsanalysis.com
Contact:
Gaurav Chaudhary
gaurav.chaudhary@rootsanalysis.com
Roots Analysis
A430, 4th Floor,
Bestech Business Towers, Sector 66, Mohali, India
sales@rootsanalysis.com
+1 (415) 800 3415
+44 (122) 391 1091
Web: https://www.rootsanalysis.com/
LinkedIn: https://in.linkedin.com/company/roots-analysis
Twitter: https://twitter.com/RootsAnalysis
Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release The on-body drug delivery-related intellectual landscape report identifies and analyzes all relevant IP publications, featuring the contributions of both established and emerging technology developers here
News-ID: 2415090 • Views: …
More Releases from Roots Analysis
Pharmacy Market Size to Hit USD 4.1 Tillion by 2035 | Exclusive Report by Roots …
The global pharmacy market, valued at USD 2.4 trillion in 2024, is estimated to reach USD 2.5 trillion in 2025 and USD 4.1 trillion by 2035, representing a CAGR of 5% during the forecast period.
The pharmacy market is broadly segmented on the basis of Market by Distribution by type of Pharmacy, Product Offered, Availability, Drug Molecule, Therapeutic Area and Key Geographical Regions.
Revolutionizing pharmacy industry: unleashing the power of technological advancements.…
Global targeted drug delivery device market is anticipated to reach to USD $2,15 …
The prevalence of chronic diseases has increased significantly over the past few decades. Presently, around 129 million people in the US have at least one life threating chronic condition, such as heart disease, cancer, diabetes, obesity or hypertension.
The global targeted drug delivery device market size is projected to grow from $427 Million in 2026 to $2,153 Million by 2035, representing a CAGR of 19.7% during the forecast period.
Additionally, about…
EMI shielding market Overview
Owing to the increasing reliant on electronic devices, the risk of electromagnetic interference (EMI) has grown. EMI occurs when electromagnetic waves generated by one device disrupt the operation of nearby electronic systems.
This interference can compromise device performance, reliability, and safety, making it a significant concern across various industries. To address this challenge, EMI shielding technologies have been developed. These involve the use of conductive or magnetic materials that either…
Biomanufacturing market is anticipated to reach to $12.0 billion by 2035with CAG …
Recognizing the potential of digitalization, biomanufacturers are increasingly adopting advanced platforms that enable operational excellence, enhance visibility, improve control, and synchronization across their bioprocessing operations
Biomanufacturing refers to a standardized process that utilizes microorganisms and other biological systems to produce and develop biomolecules as therapeutic modalities. Traditionally, the biopharmaceutical companies have hesitated to adopt cutting-edge digital technologies, such as cloud computing, artificial intelligence (AI), machine learning and internet of things (IoT),…
More Releases for Drug
Injectable Drug Delivery Market Injectable Drug Delivery Market
Leading market research firm SkyQuest Technology Group recently released a study titled ' Injectable Drug Delivery Market Global Size, Share, Growth, Industry Trends, Opportunity and Forecast 2024-2031,' This study Injectable Drug Delivery report offers a thorough analysis of the market, as well as competitor and geographical analysis and a focus on the most recent technological developments. The research study on the Injectable Drug Delivery Market extensively demonstrates existing and upcoming…
Global Advanced Drug Delivery Systems Market Size - By Product Type(Oral Drug De …
Market Overview and Report Coverage
Advanced Drug Delivery Systems (ADDS) refer to innovative technologies designed to improve the administration and efficacy of therapeutics, enhancing the way medications are delivered to targeted areas within the body. These systems aim to optimize treatment outcomes by increasing the bioavailability, reducing side effects, and facilitating controlled drug release. Employing methods such as nanoparticles, liposomes, and implantable pumps, ADDS are revolutionizing personalized medicine and expanding therapeutic…
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Pric …
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Price, and Clinical Trials Outlook 2029 Report Highlights:
* Global Antibody Drug Conjugates Market Opportunity: > 40 Billion By 2029
* Global and Regional Antibody Drug Conjugate Market Insight
* Approved Drugs Sales Insight Global and Regional, Yearly and Quarterly, 2019 -2023
* Approved Antibody Drug Conjugates - Availability, Dosage and Price Insight
* Insight On Antibody Drug Conjugates In Clinical Trials: > 550…
Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions.
Alcohol abuse and drug…
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.
Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes…
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Introduction to Hepatitis Disease
1.1 Prologue
1.1.1 History of Hepatitis
1.1.2 Causes of Hepatitis Disease
1.2 Types of Viruses which are Responsible for Hepatitis Disease
2. Global Prevalence of Hepatitis Infection
3. Available Drug Classes for Hepatitis Disease Treatment
3.1 Interferon Alfa Therapy
3.2 Protease Inhibitors Therapy
3.3 Polymerase…
